23—Haemophilus influenzae Type Vaccines
SA Nanduri, AR Sutherland, LK Gordon… - Plotkin's Vaccines …, 2017 - books.google.com
… Apache infants before the use of the Hib conjugate vaccines, … 233 The HbOC vaccine
contains oligosaccharides derived … As the pediatric immunization schedule becomes more and …
contains oligosaccharides derived … As the pediatric immunization schedule becomes more and …
Post-Licensure Impact of Haemophilus influenzae Type b and Serogroup C Neisseria meningitidis Conjugate Vaccines in Industrialized Countries
… Conjugate vaccines to prevent disease caused by Haemophilus influenzae type b (Hib)
and serogroup C meningococcus (MCC) have been used in routine national immunization …
and serogroup C meningococcus (MCC) have been used in routine national immunization …
[HTML][HTML] Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India
SP Fitzwater, P Ramachandran, GD Kahn… - Vaccine, 2019 - Elsevier
… of bacterial meningitis in infants and children below the age … to be over 95% efficacious in
preventing invasive disease (… Group on Immunization and the Indian Academy of Pediatrics…
preventing invasive disease (… Group on Immunization and the Indian Academy of Pediatrics…
[PDF][PDF] Haemophilus influenzae
M Lefebvre, G Melica - Revue des Maladies Respiratoires Actualités, 2020 - Elsevier
… Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …
vaccine in a United States population of 61,080 children. The …
[HTML][HTML] Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
C Anish, M Beurret, J Poolman - npj Vaccines, 2021 - nature.com
… proteins and medium-sized oligosaccharides end-linked to … subsequent conjugation efficiency
in vaccine manufacturing. … trial in the United States determined 94.4% efficacy of HbOC …
in vaccine manufacturing. … trial in the United States determined 94.4% efficacy of HbOC …
Vaccines Against Central Nervous System Infections: Past Achievements and Future Challenges
M Sadarangani - The Microbiology of Central Nervous System Infections, 2018 - Elsevier
… in countries using conjugate vaccines. Future challenges … from infant immunization or a lower
susceptibility of older children … a vaccine effectiveness of 83% against all capsular group B …
susceptibility of older children … a vaccine effectiveness of 83% against all capsular group B …
[HTML][HTML] Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG
…, MF Pasetti, AJ Pollard, Anti-Vi Igg Working Group - Biologicals, 2018 - Elsevier
… Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b
(… The Northern California kaiser permanente vaccine study center pediatrics group …
(… The Northern California kaiser permanente vaccine study center pediatrics group …
Staphylococcus aureus vaccines: Deviating from the carol
D Missiakas, O Schneewind - Journal of Experimental Medicine, 2016 - rupress.org
… Here we review polysaccharide-conjugate and subunit vaccines that were … subjects, typically
infants or children, to prevent childhood diseases. As … States population of 61,080 children …
infants or children, to prevent childhood diseases. As … States population of 61,080 children …
[HTML][HTML] Immunizations in hematopoietic cell transplant candidates and recipients
PL Hibberd - UpToDate., 2022 - medilib.ir
… Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …
vaccine in a United States population of 61,080 children. The …
Neuroinfectious Disease Emergencies
CRS McEntire, P Anand… - Neurologic …, 2021 - neurologic.theclinics.com
… Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC)
vaccine in a United States population of 61,080 children. The …
vaccine in a United States population of 61,080 children. The …